The AUCs of CP ratio alone for NASH prediction in NAFLD patients with normal ALT or AST, or both were 0.760 (0.560–0.960), 0.760 (0.605–0.915), 0.734 (0.516–0.951), respectively, while the AUCs of CP ratio model were 0.836 (0.659–1.000), 0.833 (0.705–0.962), and 0.821(0.612–1.000), respectively (Figures 4D–F). This evidence concerns the gene GPT and metabolic dysfunction-associated steatohepatitis.